Personalized Transcranial Magnetic Stimulation for Neck Pain (PrTMS Trial)

N/A

Recruiting

Led By Oluwaseyi Gbade-Alabi, MD

Research Sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Presence of chronic neck pain for at least 3 months

Be older than 18 years old

Must not have

Participants must not have a clinical diagnosis of insomnia

Unstable heart or pulmonary disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a therapy called Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) to see if it can help reduce chronic neck pain in military health system beneficiaries.

Who is the study for?

This trial is for military health system beneficiaries suffering from chronic neck pain. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions and agree to the study's procedures.

What is being tested?

The effectiveness of Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) in reducing chronic neck pain is being tested. Some participants will receive PrTMS while others will get a sham treatment, which does not have any therapeutic effect, for comparison.

What are the potential side effects?

While specific side effects are not listed, common ones associated with TMS may include headache, scalp discomfort at the site of stimulation, tingling or spasms of facial muscles.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had chronic neck pain for at least 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have a diagnosis of insomnia.

Select...

I do not have unstable heart or lung conditions.

Select...

I have not had a brain tumor, brain infection, stroke, or penetrating brain injury.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured to compare changes from baseline; during phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. measurements will be taken once at end of baseline, phase 1 and phase 2 and at 2, 4, and 8 weeks in follow-up for reporting.